| 1 |
33747968 | Plinabulin, a Distinct Microtubule-Targeting Chemotherapy, Promotes M1-Like Macrophage Polarization and Anti-tumor Immunity. | 2021 |
1 |
| 2 |
32508033 | Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway. | 2020 Jan |
4 |
| 3 |
29386221 | Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer. | 2018 Apr 15 |
3 |
| 4 |
28076660 | Influenza A virus NS1 protein-induced JNK activation and apoptosis are not functionally linked. | 2017 Jul |
1 |
| 5 |
26109525 | Tamoxifen-Induced Cell Death of Malignant Glioma Cells Is Brought About by Oxidative-Stress-Mediated Alterations in the Expression of BCL2 Family Members and Is Enhanced on miR-21 Inhibition. | 2015 Oct |
2 |
| 6 |
26329166 | Mitogen-activated protein kinase phosphatase 1 is involved in tamoxifen resistance in MCF7 cells. | 2015 Nov |
5 |
| 7 |
24658355 | Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity. | 2014 Feb 28 |
1 |
| 8 |
21106355 | PKCα inhibited apoptosis by decreasing the activity of JNK in MCF-7/ADR cells. | 2012 Jul |
1 |
| 9 |
19935718 | c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells. | 2010 Feb 18 |
4 |
| 10 |
18769129 | Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells. | 2008 Sep |
1 |
| 11 |
17307334 | Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells. | 2007 Jun |
3 |
| 12 |
16450001 | FADD phosphorylation is critical for cell cycle regulation in breast cancer cells. | 2006 Feb 27 |
2 |
| 13 |
16740736 | Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance. | 2006 Jun 1 |
3 |
| 14 |
15388795 | 17beta-estradiol activation of the c-Jun N-terminal kinase pathway leads to down-regulation of class II major histocompatibility complex expression. | 2005 Jan |
5 |
| 15 |
15606891 | Activated JNK brings about accelerated apoptosis of Bcl-2-overexpressing C6 glioma cells on treatment with tamoxifen. | 2005 Jan |
3 |
| 16 |
14645110 | Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin. | 2004 Mar |
3 |
| 17 |
11145737 | Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway. | 2001 Jan |
1 |
| 18 |
11085519 | Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. | 2000 Nov 1 |
6 |
| 19 |
11106684 | Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. | 2000 Dec 6 |
2 |
| 20 |
10037172 | Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance. | 1999 Feb |
1 |
| 21 |
9090707 | Activation of signal transduction kinases by tamoxifen. | 1997 Feb |
4 |